{"id":"W3118964652","doi":"10.1016/j.ijrobp.2020.12.033","title":"Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer","year":2021,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Roche","keywords":"Atezolizumab; Medicine; Tolerability; Bladder cancer; Toxicity; Adverse effect; Gemcitabine; Oncology; Internal medicine; Radiation therapy; Urology; Cancer; Gastroenterology; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113599,0.001609372,0.002418089,0.0003704998,0.0004440634,0.001210989,0.0009199025,0.00135218,0.005490152],"category_scores_gemma":[0.001013681,0.0006590654,0.001896456,0.0003041617,0.0009395871,0.001208297,0.0004082744,0.004581589,0.001144673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009408426,"about_ca_system_score_gemma":0.001308367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009834802,"about_ca_topic_score_gemma":0.003002977,"domain_scores_codex":[0.9997123,0.0001144886,0.00001065069,0.00006968408,0.00001608281,0.00007682139],"domain_scores_gemma":[0.9994986,0.000122519,0.00007742042,0.00004019546,0.00002603238,0.0002352344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8617536,0.02820926,0.00218183,0.001049251,0.001391742,0.0001166484,0.0002268046,0.00350744,0.01285109,0.0003276794,0.004409763,0.08397478],"study_design_scores_gemma":[0.7326552,0.2570027,0.004761386,0.00005366039,0.0004852116,0.0001500376,0.00007751305,0.001499513,0.001130476,0.0002976399,0.001856641,0.00003015609],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899642,0.003604271,0.0005878281,0.001182138,0.0004971006,0.001046159,0.000907117,0.0001171973,0.002094076],"genre_scores_gemma":[0.9862118,0.002552005,0.001338753,0.001370928,0.0002944652,0.001419136,0.002008223,0.00004247942,0.004762177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005490152,"threshold_uncertainty_score":0.0183664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02566606145131956,"score_gpt":0.352959636906911,"score_spread":0.3272935754555915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}